CVE-2024-29218

Description

Out-of-bounds write vulnerability exists in KV STUDIO Ver.11.64 and earlier, KV REPLAY VIEWER Ver.2.64 and earlier, and VT5-WX15/WX12 Ver.6.02 and earlier, which may lead to information disclosure or arbitrary code execution by having a user of the affected product open a specially crafted file.

Category

8.8
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.36%
Vendor Advisory keyence.com Vendor Advisory keyence.com
Affected: KEYENCE CORPORATION KV STUDIO
Affected: KEYENCE CORPORATION KV REPLAY VIEWER
Affected: KEYENCE CORPORATION VT5-WX15/WX12
Published at:
Updated at:

References

Link Tags
https://www.keyence.com/kv_vulnerability240924_en vendor advisory
https://jvn.jp/en/vu/JVNVU95439120/ third party advisory
https://www.keyence.com/kv_vulnerability240329_en vendor advisory

Frequently Asked Questions

What is the severity of CVE-2024-29218?
CVE-2024-29218 has been scored as a high severity vulnerability.
How to fix CVE-2024-29218?
To fix CVE-2024-29218, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2024-29218 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2024-29218 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2024-29218?
CVE-2024-29218 affects KEYENCE CORPORATION KV STUDIO, KEYENCE CORPORATION KV REPLAY VIEWER, KEYENCE CORPORATION VT5-WX15/WX12.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.